Riemser Arzneimittel AG sells veterinary business to Ecuphar NV

Riemser Arzneimittel AG and Belgian company Ecuphar NV have announced that they have agreed on the sale of a large part of the veterinary business of Riemser to Ecuphar. The sale should take place during the first quarter of 2011.

As part of its further strategic development as a specialty pharmaceutical supplier, Riemser Arzneimittel AG will be selling a large part of both its veterinary product portfolio and its marketing and sales unit, to Ecuphar. The research and development and production divisions, as well as the Riemser swine flu will remain at Riemser. This acquisition will grant the Belgian company Ecuphar, which is specialised in veterinary medicine, direct access to the German veterinary market, an important factor in its European expansion strategy. In the future, Ecuphar will operate in Germany under the name of Ecuphar GmbH. The Company will be located in Greifswald, Germany.